Kyushu University · Medicine
Professor Yoshimasa Shiraishi's research lab specializes in clinical and surgical management of drug-resistant tuberculosis, with a particular focus on extensively drug-resistant tuberculosis (XDR-TB). The lab investigates the role of pulmonary resection as a therapeutic option for patients with advanced or refractory forms of the disease, especially in cases where medical therapy alone is insufficient. Their work contributes to the development of evidence-based surgical strategies in the context of global TB control challenges. The lab also emphasizes multidisciplinary approaches combining thoracic surgery, infectious disease management, and public health surveillance.
Figures are computed from collected data and may differ slightly.
Japan Registry of Clinical Trials Identifier: jRCT2080224500.
Extensively drug-resistant tuberculosis is becoming a global threat. It is a relatively new phenomenon, and its optimal management remains undetermined. We report our experience in using pulmonary resection for treating patients with this disease. Records were reviewed of 54 consecutive patients undergoing a pulmonary resection for multidrug-resistant tuberculosis at Fukujuji Hospital between 2000 and 2006. These patients were identified using the definition approved by the World Health Organiza
Open papers in the app to read, cite, and organize with AI.
